Fulgent Genetics
FLGT
179 hedge funds and large institutions have $469M invested in Fulgent Genetics in 2025 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 54 increasing their positions, 55 reducing their positions, and 14 closing their positions.
593% more call options, than puts
Call options by funds: $6.37M | Put options by funds: $919K
143% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 14
20% more capital invested
Capital invested by funds: $389M → $469M (+$79.6M)
10% more funds holding
Funds holding: 163 → 179 (+16)
1.46% more ownership
Funds ownership: 56.28% → 57.75% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 55
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$18.3M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$5.23M |
| 3 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$4.4M |
| 4 |
Goldman Sachs
New York
|
+$4.27M |
| 5 |
Two Sigma Investments
New York
|
+$3.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$13.7M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$6.33M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.48M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$3.33M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$2.87M |
FLGT Hedge Fund Activity: Q4 2025 in Review
179 of the 8,224 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q4 2025, worth a combined $469M — up 20% from $389M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new FLGT positions and 14 closed out — a net gain of 20 holders — while 54 added to existing stakes and 55 trimmed.
The largest buyer was RTW Investments, opening a new position worth an estimated $18.3M. The largest seller was Millennium Management, cutting an estimated $13.7M.
- 179 institutional investors held Fulgent Genetics (FLGT) as of Q4 2025, up from 163 in Q3 2025.
- Funds reported $469M of Fulgent Genetics stock for Q4 2025, up 20% quarter-over-quarter.
- 34 funds opened new Fulgent Genetics positions in Q4 2025 and 14 closed out, a net change of +20 holders.
- The largest Fulgent Genetics buyer in Q4 2025 was RTW Investments, an estimated $18.3M added.
- The largest Fulgent Genetics seller in Q4 2025 was Millennium Management, an estimated $13.7M sold.
Based on aggregated 13F filings for Q4 2025.